Full Agonists vs Partial Agonists: Understanding Drug Efficacy
The distinction between full and partial agonists is fundamental to pharmacology. Learn how intrinsic efficacy determines a drug's maximal response and clinical implications.
Pharmacology articles
Educational information only, not medical advice; consult a qualified professional.
Accessible explanations of receptor pharmacology. Educational information only, not medical advice; consult a qualified professional.
Inverse Agonists: Drugs That Do the Opposite
Inverse agonists bind receptors and reduce activity below basal levels — a pharmacological concept that challenges traditional agonist/antagonist thinking. Learn how they work and where they are used clinically.
Beta-2 Agonists in Asthma Treatment
Beta-2 agonists are among the most widely used drugs in medicine, forming the backbone of asthma and COPD management. Learn how they relax airways and how SABAs and LABAs differ.
Opioid Agonists and the Analgesic Effect
Opioid agonists are the most powerful analgesics available, but their pharmacology is complex and their risks are substantial. This guide explains how they produce analgesia and their clinical use.
Receptor Desensitization and Drug Tolerance Mechanisms
Drug tolerance — when a drug becomes less effective with repeated use — is rooted in receptor desensitization and downregulation. Understanding these mechanisms explains why tolerance develops and how to manage it.
Allosteric Modulators: Shaping Receptor Function Without Direct Activation
Allosteric modulators bind to receptor sites distinct from the orthosteric binding site, changing receptor conformation and modifying agonist responses — enabling highly targeted drug design.
What Is a Receptor Agonist? A Plain-Language Introduction
A plain-language introduction to receptor agonists: what receptors are, how natural messengers and medicines switch them on, and why affinity and efficacy matter.
Agonists vs Antagonists: How Drugs Turn Receptors On and Off
How agonists activate receptors while antagonists block them, the difference between competitive and non-competitive antagonism, and real examples such as naloxone and beta-blockers.
Dose-Response Curves Explained: Potency, Efficacy and EC50
A clear explanation of dose-response curves in pharmacology: what EC50 and Emax mean, how potency differs from efficacy, and how quantal curves lead to the therapeutic index.
G Protein-Coupled Receptors: The Largest Family of Drug Targets
An introduction to G protein-coupled receptors (GPCRs): their seven-helix structure, the Gs, Gi and Gq signalling pathways, arrestins, and familiar medicines that act on them.
Biased Agonism: When One Receptor Sends Different Signals
What biased agonism (functional selectivity) means, how G protein and arrestin pathways differ, why it attracted interest for opioid research, and why its clinical value is still debated.
Receptor Selectivity: Why Drugs Act on Some Targets and Not Others
What receptor selectivity means in pharmacology, why it is relative rather than absolute, and how subtypes, tissue location and delivery route shape a drug's effects and side effects.
Ligand-Gated Ion Channels: Fast Receptors and Their Agonists
How ligand-gated ion channels such as nicotinic, GABA-A, glycine, 5-HT3 and glutamate receptors work, how agonists open them within milliseconds, and how modulators differ from agonists.
Nuclear Receptor Agonists: Steroids, Thyroid Hormone and PPARs
How nuclear receptors work as ligand-activated transcription factors, and how agonists such as corticosteroids, thyroid hormone, PPAR agonists and vitamin D analogues change gene expression.
Adrenergic Agonists: Alpha-1, Alpha-2 and Beta Receptors Explained
A guide to adrenergic receptor agonists: how alpha-1, alpha-2, beta-1, beta-2 and beta-3 receptors differ, and familiar examples from decongestants and eye drops to bladder medicines.
Cholinergic Agonists: How Drugs Mimic Acetylcholine
How cholinergic agonists act on muscarinic and nicotinic acetylcholine receptors, examples such as pilocarpine and bethanechol, how they differ from cholinesterase inhibitors, and key cautions.
Dopamine Receptor Agonists: Mechanism and Clinical Context
How dopamine receptor agonists work: D1-like and D2-like receptors, why the class is used in Parkinson's disease, restless legs syndrome and high prolactin, and the main known cautions.
Serotonin Receptor Agonists: From Migraine Treatment to Research
An overview of serotonin (5-HT) receptor families and the agonists that act on them: triptans and ditans for migraine, 5-HT1A partial agonists, and safety lessons such as the 5-HT2B receptor.
GLP-1 Receptor Agonists: How This Drug Class Works
How GLP-1 receptor agonists work: the natural incretin hormone GLP-1, why the native hormone is short-lived, how drug versions were modified, and the main effects and cautions.
A Short History of the Receptor Concept: From Langley and Ehrlich to Modern Pharmacology
How the idea of drug receptors developed: Langley's receptive substance, Ehrlich's chemoreceptors, Clark's occupancy theory, efficacy, adrenoceptor subtypes and the structural era.